1988
DOI: 10.3109/00016488809125094
|View full text |Cite
|
Sign up to set email alerts
|

Laserthermia on Head and Neck Malignancies— Experimental and Clinical Studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

1992
1992
1999
1999

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 9 publications
0
7
0
Order By: Relevance
“…ILTT is based on interstitial tissue destruction by means of laser coagulation as well as hyperthermia and was described first by Bown in 1983 [7]. Since then several experimental and clinical studies in liver [37], pancreas [14], prostate [40], head and neck [26] and brain have been performed [31,39]. The purpose of this article is to present the current status of ILTT for the treatment of intracranial tumours, to discuss its possibilities in neurosurgery, and to suggest possible improvements.…”
Section: Introductionmentioning
confidence: 99%
“…ILTT is based on interstitial tissue destruction by means of laser coagulation as well as hyperthermia and was described first by Bown in 1983 [7]. Since then several experimental and clinical studies in liver [37], pancreas [14], prostate [40], head and neck [26] and brain have been performed [31,39]. The purpose of this article is to present the current status of ILTT for the treatment of intracranial tumours, to discuss its possibilities in neurosurgery, and to suggest possible improvements.…”
Section: Introductionmentioning
confidence: 99%
“…The Nd:YAG laser operating at 1,064 nm has generally been preferred since there is relatively good light penetration in soft tissues at this wavelength [61. While still experimental, ILP has been used both interstitially and in contact mode to treat unresectable localized human tumors in brain 171, head and neck [8,9], liver, breast, and pancreas [lo-121. Most of the experimental work has involved assessing safety and efficacy using animal models [2,3, and determining appropriate technical parameters [18-211. A central problem in interstitial heating is that the size and geometry of thermal lesions are difficult to predict due to the variability of blood flow in living tissues.…”
Section: Introductionmentioning
confidence: 99%
“…3 Furthermore, hyperthermia has been shown to reduce blood flow at the heated area around the probe while increasing blood flow at the margin. 4 Increased blood flow at the margin of hyperthermia may increase the concentration of chemotherapeutic agents and tissue oxygen, thus enhancing the antitumor effect of chemotherapy or radiation when combined with hyperthermia.…”
Section: Discussionmentioning
confidence: 99%